News

The randomized, double-blind study is the company’s second cancer therapy approved for clinical trials by the FDA, bolstering its platform approach to treating late stage solid-tumor cancers. The

Under the terms of the merger agreement, which has been approved by the company’s board upon the recommendation of the board’s transaction committee of independent and disinterested directors,

Walgreens Connected Care is an education and support plan designed to help patients achieve a sustained virologic response (SVR) and improved quality of life through medication adherence. The

MuGard is a mucoadhesive hydrogel. The randomized, double-blind, placebo-controlled trial showed MuGard was more effective than a sham-control in significantly reducing pain associated with oral mucositis, a common

Qu Biologics co-founder and CEO Dr Hal Gunn noted significant patient interest from the US in its Crohn’s disease clinical trial prompted us to open the trial to

Crohn’s disease is a chronic condition for which there is currently no satisfactory cure able to increase the quality of life for people who have Crohn’s disease. DBV

A total of 45 patients with mild to moderate ulcerative colitis are enrolled in the trial, which is designed to assess the safety, efficacy, pharmacokinetics and effects on

In 2011, the companies have signed a worldwide agreement to develop and market tivozanib outside of Asia for the treatment of a broad range of cancers As part

Under the deal, Moberg Pharma has been granted Menarini Asia-Pacific the exclusive rights to market and sell Kerasal Nail in eight Southeast Asian countries. The deal builds on